IOP Reduction in Pigmentary Glaucoma Using DSLT

Part of paid clinical trials in Houston, Texas.

Sponsor
Mann Eye Institute
Study ID
NCT07281391
Status
Recruiting

Conditions

  • Pigmentary Dispersion Glaucoma
  • Pigmentary Dispersion Syndrome

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Voyager DSLT — DEVICE
    DSLT is an innovative adaptation of traditional SLT. Rather than using a gonioscopic lens, DSLT applies laser energy directly through the limbus to the trabecular meshwork in a few seconds.

Study Details

This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.

Key Dates

Start date
Mar 19, 2026
Status verified
Apr 2026
Primary completion
Apr 1, 2027
Completion
Apr 1, 2027

Study Design

Enrollment
45 participants (estimated)

Primary Outcome Measure

Mean washed-out IOP change post-DSLT compared to washed-out baseline IOP [ Time Frame: 6 months post-DSLT ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mann Eye InstituteHoustonTexas76134-2099
Melissa Hamann Wright
713-580-2500
Alex Hacopian, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX